Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Drug-Eluting Stent Trends and Forecast
The future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Drug-Eluting Stent by Segment
The study includes a forecast for the global drug-eluting stent by coating type, application, and region.
Drug-Eluting Stent Market by Coating Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug-eluting stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-
Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.
Within this market, coronary artery disease will remain larger segment due to increasing global incidence of coronary artery disease.
North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.
Features of the Global Drug-Eluting Stent Market
Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).
Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug-eluting stent market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the drug-eluting stent market size?
Answer: The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030.
Q2. What is the growth forecast for drug-eluting stent market?
Answer: The global drug-eluting stent market is expected to grow with a CAGR of 6.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the drug-eluting stent market?
Answer: The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.
Q4. What are the major segments for drug-eluting stent market?
Answer: The future of the drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets.
Q5. Who are the key drug-eluting stent market companies?
Answer: Some of the key drug-eluting stent companies are as follows:
Answer: Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.
Q7. In drug-eluting stent market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Drug-Eluting Stent Market, Drug-Eluting Stent Market Size, Drug-Eluting Stent Market Growth, Drug-Eluting Stent Market Analysis, Drug-Eluting Stent Market Report, Drug-Eluting Stent Market Share, Drug-Eluting Stent Market Trends, Drug-Eluting Stent Market Forecast, Drug-Eluting Stent Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Drug-Eluting Stent Trends and Forecast
The future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Drug-Eluting Stent by Segment
The study includes a forecast for the global drug-eluting stent by coating type, application, and region.
Drug-Eluting Stent Market by Coating Type [Shipment Analysis by Value from 2018 to 2030]:
- Polymer-Based Coating
- Polymer-Free Coating
- Coronary Artery Disease
- Peripheral Artery Disease
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug-eluting stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-
- Boston Scientific
- Medtronic
- Abbott Laboratories
- Biosensors
- Biotronik
- Lepu Medical Technology
- Terumo Medical
- Cook Medical
- Shandong JW Medical Systems
- B.Braun
Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.
Within this market, coronary artery disease will remain larger segment due to increasing global incidence of coronary artery disease.
North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.
Features of the Global Drug-Eluting Stent Market
Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).
Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug-eluting stent market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the drug-eluting stent market size?
Answer: The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030.
Q2. What is the growth forecast for drug-eluting stent market?
Answer: The global drug-eluting stent market is expected to grow with a CAGR of 6.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the drug-eluting stent market?
Answer: The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.
Q4. What are the major segments for drug-eluting stent market?
Answer: The future of the drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets.
Q5. Who are the key drug-eluting stent market companies?
Answer: Some of the key drug-eluting stent companies are as follows:
- Boston Scientific
- Medtronic
- Abbott Laboratories
- Biosensors
- Biotronik
- Lepu Medical Technology
- Terumo Medical
- Cook Medical
- Shandong JW Medical Systems
- B.Braun
Answer: Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.
Q7. In drug-eluting stent market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Drug-Eluting Stent Market, Drug-Eluting Stent Market Size, Drug-Eluting Stent Market Growth, Drug-Eluting Stent Market Analysis, Drug-Eluting Stent Market Report, Drug-Eluting Stent Market Share, Drug-Eluting Stent Market Trends, Drug-Eluting Stent Market Forecast, Drug-Eluting Stent Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL DRUG-ELUTING STENT MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Drug-Eluting Stent Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Drug-Eluting Stent Market by Coating Type
3.3.1: Polymer-Based Coating
3.3.2: Polymer-Free Coating
3.4: Global Drug-Eluting Stent Market by Application
3.4.1: Coronary Artery Disease
3.4.2: Peripheral Artery Disease
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Drug-Eluting Stent Market by Region
4.2: North American Drug-Eluting Stent Market
4.2.1: North American Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.2.2: North American Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.3: European Drug-Eluting Stent Market
4.3.1: European Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.3.2: European Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.4: APAC Drug-Eluting Stent Market
4.4.1: APAC Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.4.2: APAC Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.5: ROW Drug-Eluting Stent Market
4.5.1: ROW Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.5.2: ROW Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
6.2: Emerging Trends in the Global Drug-Eluting Stent Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Boston Scientific
7.2: Medtronic
7.3: Abbott Laboratories
7.4: Biosensors
7.5: Biotronik
7.6: Lepu Medical Technology
7.7: Terumo Medical
7.8: Cook Medical
7.9: Shandong JW Medical Systems
7.10: B.Braun
2. GLOBAL DRUG-ELUTING STENT MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Drug-Eluting Stent Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Drug-Eluting Stent Market by Coating Type
3.3.1: Polymer-Based Coating
3.3.2: Polymer-Free Coating
3.4: Global Drug-Eluting Stent Market by Application
3.4.1: Coronary Artery Disease
3.4.2: Peripheral Artery Disease
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Drug-Eluting Stent Market by Region
4.2: North American Drug-Eluting Stent Market
4.2.1: North American Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.2.2: North American Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.3: European Drug-Eluting Stent Market
4.3.1: European Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.3.2: European Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.4: APAC Drug-Eluting Stent Market
4.4.1: APAC Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.4.2: APAC Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
4.5: ROW Drug-Eluting Stent Market
4.5.1: ROW Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
4.5.2: ROW Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
6.2: Emerging Trends in the Global Drug-Eluting Stent Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Boston Scientific
7.2: Medtronic
7.3: Abbott Laboratories
7.4: Biosensors
7.5: Biotronik
7.6: Lepu Medical Technology
7.7: Terumo Medical
7.8: Cook Medical
7.9: Shandong JW Medical Systems
7.10: B.Braun
